Abdullah Katgi

Abdullah Katgi

Auto-generated profile, based on publicly available information

Abdullah Katgi

Department of Hematology, Dokuz Eylul University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2015 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
PDF file
OSOmur Gokmen Sevindik
Omur Gokmen Sevindik
ZGZeynep Guc
Zeynep Guc
SKSelda Kahraman
Selda Kahraman
SSSerife Medeni Solmaz
Serife Medeni Solmaz
AKAbdullah Katgi
Abdullah Katgi
MOMehmet Ali Ozcan
Mehmet Ali Ozcan
The serum albumin (SA) level has been reported to be an independent prognostic biomarker that may serve as a surrogate representative of disease biology in patients diagnosed with myelodysplastic syndrome (MDS). However, its prognostic ability has not been tested in a model adjusting for comorbidities. We analyzed 200 patients who were diagnosed as having de novo MDS. Median overall survival (OS) of all patients was 25 months and median leukemia-free survival (LFS) was 24 months. Median OS according to the SA level groups of ≤ 3.5, 3.6–4.0 and > 4.0 mg/dL were 24, 39 and 77 months, respectively. SA level remained an independent predictor of both LFS and OS even when adjusting for the hematopoietic cell transplant comorbidity index (HCT-CI) and the International Prognostic Scoring System (IPSS) or World Health Organization classification-based Prognostic Scoring System (WPSS). Our findings indicate that SA level at the time of diagnosis is a significant and independent predictor of LFS and OS even when adjusting for commonly used prognostic systems and comorbidities.

1 January 2012 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
AKAbdullah Katgi
Abdullah Katgi
PAPinar Ataca
Pinar Ataca
SKSelda Kahraman
Selda Kahraman
ÖPÖzden Pişkin
Özden Pişkin
MÖMehmet A. Özcan
Mehmet A. Özcan
BÜBülent Ündar
Bülent Ündar
Acquired hemophilia is a rare, life-threatening coagulopathy in adults caused by the development of autoantibodies against factor VIII. Bypass agents such as recombinant factor VIIa (rFVIIa) are usually preferred for bleeding control; however, thromboembolic complications may occur. We report here a case that presented with extensive cutaneous and mucosal bleedings due to factor VIII inhibitors and was treated successfully with rFVIIa and steroid therapy, but was complicated with a life-threatening thromboembolic attack during follow-up.

1 March 2013 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
AKAbdullah Katgi
Abdullah Katgi
PAPinar Ataca
Pinar Ataca
SKSelda Kahraman
Selda Kahraman
OSOmur Gokmen Sevindik
Omur Gokmen Sevindik
USUlker Sonmez
Ulker Sonmez
GOGuner Hayri Ozsan
Guner Hayri Ozsan
Gray platelet syndrome (GPS) is a rare inherited disorder characterized by the absence of α-granules and their constituents. It may be present with thrombocytopenia and bleeding tendency. Platelets have a large and gray appearance under light and electron microscope. A 19-year old female patient with her second relapse acute lymphoblastic leukemia had to be consolidated with allo-hematopoietic stem cell transplantation (HSCT) after achieving remission with induction chemotherapy. The only available and one mismatch compatible donor was her brother, who was previously diagnosed as GPS. Allogeneic HSCT was performed from her brother in spite of GPS, and successful neutrophil and platelet engraftment achieved at the 12th and 42nd day of reinfusion, consecutively. The engrafted and circulating thrombocytes were large and gray and had little or no α-granules under electron microscope. The patient was well with no major bleeding event and increased need for thrombocyte replacement until developing bronchiolitis obliterans organizing pneumonia and respiratory distress syndrome. Thereafter death occurred. This is the first case of successful thrombocyte engraftment with documented gray thrombocyte megakaryopoiesis after allogeneic HSCT from a GPS donor. The only noteworthy issue was the slight prolongation of engraftment.